This is very very small number trial even in the large number trial unexpected good performance of placebo arm(in this case sham treatment) can impact the outcome of a clinical trial. Longer time observation is needed before giving up completely. With the company previously facing issues with Type 1 diabetes trial, they will make sure they do everything by the book. Unblinding at this stage depends on protocol if the decision for extension was per protocol than it may be ok for the study to remain blinded that appears to the case from the announcement.
LCT Price at posting:
4.0¢ Sentiment: None Disclosure: Not Held
